Abstract: Vitamin B 12 (VB 12 ) was investigated for its ability to influence the expression of genes required for cardiac cell differentiation from mouse embryonic stem cells. When VB 12 (0.5 mM) was added to the medium on day 3 of culture, the levels of Cx40 and HCN4 expression increased over those in the control, 2 to 3 days before the start of cardiomyocyte beating. In contrast, the expression levels of a-MHC, MLC-2a, and MLC-2v were almost the same as those of the control throughout the culture period. Our results suggest that VB 12 is involved in the promotion of the intercellular conducting system rather than the generation of contractile proteins. [3] . However it is still difficult to prepare cell clusters or tissues of sufficient size and purity for cell therapy or transplantation.
The pluripotency of embryonic stem (ES) cells and the potential of ES cells for use in regenerative therapies are well known. To date, ES cells have been induced to differentiate into haematocytes, neurons, glia, epithelial cells, endothelial cells, yolk sac, adipocytes, pancreatic islet cells, chondrocytes, skeletal myocytes, smooth muscle cells, and cardiomyocytes in appropriate in vitro induction systems [3] . However it is still difficult to prepare cell clusters or tissues of sufficient size and purity for cell therapy or transplantation.
Our interest lies in cardiomyocyte differentiation. In order to identify novel differentiation factors, we screened several herbal medicines and found that Panax ginseng can promote the rate of differentiation. Among the components of P. ginseng, vitamin B 12 (VB 12 ) was found to be the most effective for accelerating the differentiation of beating cells as well as for maintaining of their beating [11] .
In this study, we investigated the effect of VB 12 on the expression of genes that are involved in cardiomyocyte differentiation. Cardiac differentiation related genes are categorized into three classes; (1) cardiac specific transcription factors (GATA4 and Nkx2.5); (2) principal muscle contractile proteins (a-MHC, b-MHC, MLC-2a, and MLC-2v); and (3) conducting system components (Cx40 and HCN4). We selected 6 genes (GATA4, a-MHC, MLC-2a, Cx40 , and HCN4) to analyze the influence of VB 12 on patterns of their expression.
The ES cell line, 129line/R-CMTI-1, was maintained in an undifferentiated state on 0.1% gelatin-coated dishes with feeder layer cells (prepared by incubation with mitomycin C) and murine leukemia inhibition factor (LIF) (ESGRO; Chemicon International Inc., Temecula, CA) at 37°C under an atmosphere of 5% CO 2 -Note- [12] . In the experiments described below, the cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) with high glucose, supplemented with 15% fetal bovine serum (FBS) (ES cell qualified, Invitrogen, CA), 0.1 mM 2-mercaptoethanol, 1 mM sodium pyruvate, 1% nonessential amino acids solution (100×) (Invitrogen), 1% penicillin-streptomycin (Invitrogen), 1% nucleoside solution for ES cell (100×) (dS Pharma Biomedical Co., Osaka) and 1,000 U/ml LIF.
ES cells were collected from the cultures after treatment with 0.1% trypsin-EdTA solution (Invitrogen). Single-cell suspensions were used to estimate the numbers of cells. Hanging drops, each containing about 2,000 cells in 20 µl of medium containing no LIF, were prepared on the lid of a dish containing PBS (day 0), and incubated for 2 days [1, 2] . Embryoid bodies (EBs) that formed in the hanging drops were then transferred individually to 24-well plates coated with 0.1% gelatin (day 2), and incubated in ES cell culture medium without LIF. The next day (day 3), the medium was replaced by a differentiation medium with 0.5 mM VB 12 or without VB 12 (control), and cultured for an additional 9 days (day 12). during cardiomyocyte differentiation, the effect of VB 12 on the expression of the cardiac marker genes (a-MHC, Cx40, GATA4, HCN4, MLC-2a, and MLC-2v) was examined by semi-quantitative RT-PCR. Total RnA was extracted from differentiated cells using ISOGEn (nippon Gene, Co., Ltd., Tokyo) according to the manufacturer's protocol. For semi-quantitative RT-PCR analysis, 8 µg of total RnA was reverse-transcribed using SuperScript II reverse transcriptase (Invitrogen), and an aliquot containing 1/30th of the cdnA was subjected to PCR amplification for 23-32 cycles of 94℃ for 60 s, 60℃ for 60 s, and 72℃ for 60 s, using the appropriate primer sets (Table 1) . Amplified cDNAs were electrophoresed on 1.2% agarose gels, stained with ethidium bromide, and band densities were determined by densitometry with nIH IMAGE software (the Research Service Branch of the National Institute of Health). Optimization of the semi-quantitative RT-PCR assay was carried out using the method of Kawai et al. [6] . Briefly, the most appropriate number of PCR cycles for the semi-quantitative analysis for each experiment was carefully determined in several preliminary experiments. All experiments were repeated a minimum of three times using 12-48 EBs in each experiment. data are expressed as means ± standard deviation. Student's t-test was used to compare the means, and differences with P<0.05 were considered statistically significant.
On day 0, none of the target genes showed any expression, but all six were expressed from day 4 onwards. The expression level of Cx40 was significantly greater than that of the control on day 5, and that of HCN4 on day 4. Beating cardiomyocytes appeared on day 7 and VB 12 increased the rate of cardiac differentiation [9] . Thus, Cx40 and HCN4 displayed significantly increased levels of expression 2 to 3 days before differentiating cardiomyocytes commenced beating. The expression levels of other genes did not show significant differences in the presence or the absence of VB 12 throughout the experimental period (Fig. 1) .
Cx40 encodes gap junctions and gap junctional channels are essential for action potential propagation from the sinoatrial node to working cardiomyocytes in the heart [8] . The HCn4 channel generates an inward current that plays a crucial role in the autonomous rhythmic activity of cardiac cells [7] . VB 12 accelerates Cx40 and HCN4 gene expression at an early stage of cardiomyocyte differentiation, suggesting the formation of a cellular communication and conducting system, which may result in the initiation of beating of EBs earlier than in controls. This mechanism appears to be unique to VB 12 because other factors reported so far, e.g., ascorbic acid [13] , retinoic acid [14] , 5-azacytidine, nitric oxide, and several cytokines [10] , induce cardiomyocyte differentiation by promoting production of contractile proteins [4, 5] . Although the present study analyzed gene transcription only, it is expected that the protein products of these genes would also have increased in a manner similar to that described elsewhere [9] . On the other hand, the Cx40 promoter contains specific sites for interaction with GATA4 and nkx2.5 [8] . GATA4 was induced as early as day 4 by the addition of VB 12 , although without significant difference from controls. This early appearance of GATA4 was in good agreement with the early induction of Cx40. The present findings provide new insight into the molecular mechanism of cardiomyocyte differentiation.
